![4-Morpholinecarboximidamide,N-[3-[(1S)-1-(2-fluoro[1,1'-biphenyl]-4-yl)ethyl]-5-isoxazolyl]-](https://static.cymitquimica.com/cas-image/394108-4-morpholinecarboximidamide-n-3-1s-1-2-fluoro-11-biphenyl-4-yl-ethyl-5-isoxazolyl.png)
CAS: 215174-50-8 - 4-Morpholinecarboximidamide,N-[3-[(1S)-1-(2-fluoro[1,1'-biphenyl]-4-yl)ethyl]-5-isoxazolyl]-
Fórmula:C22H23FN4O2
- Sinónimos:
- Rimacalib
- Smp 114
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Rimacalib REF: TR-R505015CAS: 215174-50-8 | - - - | 275,00 €~1.819,00 € | Lun 13 May 24 |
| Rimacalib Morpholine D8 REF: TR-R505017CAS: 215174-50-8 | - - - | 13.286,00 € | Jue 13 Jun 24 |
 | Rimacalib REF: 3D-FR177034CAS: 215174-50-8 | Min. 95% | A consultar | Vie 14 Jun 24 |
 | Rimacalib REF: TM-T16752CAS: 215174-50-8 | 98% | A consultar | Vie 21 Jun 24 |
Rimacalib
Producto controladoCAS:215174-50-8
Fórmula:
C22H23FN4O2
Forma y color:
Off-White to Light Orange Solid
Peso molecular:
394.45
Ref: TR-R505015
| 1mg | 275,00 € | |
| 10mg | 1.819,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
Rimacalib Morpholine D8
Producto controladoCAS:215174-50-8
Fórmula:
C22H15D8FN4O2
Peso molecular:
402.491
Ref: TR-R505017
| 50mg | 13.286,00 € |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024
Rimacalib
CAS:215174-50-8
Rimacalib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the group of drugs known …
Fórmula:
C22H23FN4O2
Pureza:
Min. 95%
Peso molecular:
394.44 g/mol
Ref: 3D-FR177034
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 14 de Junio de 2024
Rimacalib
CAS:215174-50-8
Rimacalib is an inhibitor of Ca2+/calmodulin-dependent protein kinase II (IC50s: ~1 μM for CaMKIIα and …
Fórmula:
C22H23FN4O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
394.44
Ref: TM-T16752
| 25mg | 1.410,00 € | |
| 50mg | 1.845,00 € | |
| 100mg | 2.329,00 € |
Entrega estimada en Estados Unidos, el Viernes 21 de Junio de 2024
